Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The real McCoy?

Autor: Floyd CN (AUTHOR)

Publikováno v: Lancet. 5/19/2012, Vol. 379 Issue 9829, pe52-e52. 1p.

Influence of Blood Pressure Reduction on Pulse Wave Velocity in Primary Hypertension: A Meta-Analysis and Comparison With an Acute Modulation of Transmural Pressure.

Autor: McNally RJ; King's College London, Department of Vascular Risk and Surgery, British Heart Foundation Centre, United Kingdom (R.J.M., C.N.F., M.C., B.F., P.C., L.F.)., Boguslavskyi A; Cardiac Outpatient Department, Guy's and St. Thomas' NHS Foundation Trust, London, United Kingdom (A.B.)., Malek R; King's College London, School of Life Course and Population Sciences, United Kingdom (R.M., A.D.)., Floyd CN; King's College London, Department of Vascular Risk and Surgery, British Heart Foundation Centre, United Kingdom (R.J.M., C.N.F., M.C., B.F., P.C., L.F.)., Cecelja M; King's College London, Department of Vascular Risk and Surgery, British Heart Foundation Centre, United Kingdom (R.J.M., C.N.F., M.C., B.F., P.C., L.F.)., Douiri A; King's College London, School of Life Course and Population Sciences, United Kingdom (R.M., A.D.)., Bruno RM; Université Paris Cité, INSERM U970 Team 7, Paris Cardiovascular Research Centre - PARCC, France (R.-M.B.)., Farukh B; King's College London, Department of Vascular Risk and Surgery, British Heart Foundation Centre, United Kingdom (R.J.M., C.N.F., M.C., B.F., P.C., L.F.)., Chowienczyk P; King's College London, Department of Vascular Risk and Surgery, British Heart Foundation Centre, United Kingdom (R.J.M., C.N.F., M.C., B.F., P.C., L.F.)., Faconti L; King's College London, Department of Vascular Risk and Surgery, British Heart Foundation Centre, United Kingdom (R.J.M., C.N.F., M.C., B.F., P.C., L.F.).

Publikováno v: Hypertension (Dallas, Tex. : 1979) [Hypertension] 2024 Jul; Vol. 81 (7), pp. 1619-1627. Date of Electronic Publication: 2024 May 09.

Unexpected high HbA1c results due to an unusual haemoglobin variant: an important clinical lesson.

Autor: Floyd CN; Department of Clinical Pharmacology, Guy's and St Thomas' Hospitals NHS Trust, London, UK.; King's College London British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences, King's College London, London, UK., Brady S; Department of Chemical Pathology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Monteiro D; Department of Special Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Nathan Y; Department of Diabetes, University Hospital, Lewisham and Greenwich Trust, London, UK., Crook M; Department of Chemical Pathology, Guy's and St Thomas' NHS Foundation Trust, London, UK martin.crook@doctors.org.uk.; Department of Clinical Biochemistry and Metabolic Medicine, Guy's and St Thomas' and Lewisham and Greenwich Trust, London, UK.

Publikováno v: Postgraduate medical journal [Postgrad Med J] 2022 May; Vol. 98 (1159), pp. 331-332. Date of Electronic Publication: 2021 Jan 15.

Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.

Autor: Magavern EF; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.; Department of Clinical Pharmacology, Cardiovascular Medicine, Barts Health NHS Trust, London, UK., Kaski JC; Molecular and Clinical Sciences Research Institute, St George's University of London, London, UK., Turner RM; The Wolfson Centre for Personalised Medicine, Institute of Systems, Molecular and Integrative Biology (ISMIB), University of Liverpool, Liverpool, UK.; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK., Drexel H; Vorarlberg Institute for Vascular Investigation & Treatment (VIVIT), Feldkirch,Austria.; Private University of the Principality of Liechtenstein, Triesen, Liechtenstein.; Drexel University College of Medicine, Philadelphia, PA, USA., Janmohamed A; Department of Clinical Pharmacology, St George's University of London, London, UK., Scourfield A; Department of Clinical Pharmacology, University College London Hospital Foundation Trust, London, UK., Burrage D; Whittington Health NHS Trust, London, UK., Floyd CN; King's College London British Heart Foundation Centre, School of Cardiovascular Medicine and Sciences, London, UK.; Department of Clinical Pharmacology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Adeyeye E; Department of Clinical Pharmacology, Cardiovascular Medicine, Barts Health NHS Trust, London, UK., Tamargo J; Department of Pharmacology and Toxicology, School of Medicine, Universidad Complutense de Madrid, Madrid, Spain., Lewis BS; Cardiovascular Clinical Research Institute, Lady Davis Carmel Medical Center and the Ruth and Bruce Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa, Israel., Kjeldsen KP; Department of Cardiology, Copenhagen University Hospital (Amager-Hvidovre), Copenhagen, Denmark.; Department of Health Science and Technology, Faculty of Medicine, Aalborg University, Aalborg, Denmark., Niessner A; Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria., Wassmann S; Cardiology Pasing, Munich,Germany.; University of the Saarland, Homburg/Saar, Germany., Sulzgruber P; Division of Cardiology, Department of Medicine II, Medical University of Vienna, Vienna, Austria., Borry P; Center for Biomedical Ethics and Law, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.; Leuven Institute for Human Genetics and Society, Leuven, Belgium., Agewall S; Oslo University Hospital Ullevål and Institute of Clinical Sciences, University of Oslo, Oslo, Norway., Semb AG; Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Innovation and Research, Diakonhjemmet Hospital, Oslo, Norway., Savarese G; Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm,Sweden.; Sweden Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden., Pirmohamed M; The Wolfson Centre for Personalised Medicine, Institute of Systems, Molecular and Integrative Biology (ISMIB), University of Liverpool, Liverpool, UK.; Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.; Liverpool Health Partners, Liverpool, UK., Caulfield MJ; William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

Publikováno v: European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2022 Jan 05; Vol. 8 (1), pp. 100-103.